Jade Biosciences Ownership | Who Owns Jade Biosciences?


OverviewForecastChart

Jade Biosciences Ownership Summary


Jade Biosciences is owned by 52.56% institutional investors, 0.04% insiders, and 47.40% retail investors. Fmr is the largest institutional shareholder, holding 22.59% of JBIO shares.

JBIO Ownership Benchmark


TypeName% Inst% Insiders% Retail
StockJade Biosciences52.56%0.04%47.40%
SectorHealthcare Stocks 232.80%10.63%-143.43%
IndustryBiotech Stocks 379.48%10.37%-289.85%

Institutional Shareholders


Top Institutional Shareholders by Total Shares

HolderShares% HoldingValue
Fmr7.09M22.59%$99.55M
Fairmount funds management4.55M14.52%$63.98M
Ra capital management3.67M11.71%$51.58M
Bellevue group3.50M11.17%$49.20M
Vr adviser3.22M10.27%$45.25M
Janus henderson group3.11M9.90%$43.56M
Blackrock funding, inc. /de2.31M7.38%$32.51M
Vanguard group2.10M5.29%$32.34M
Baker bros. advisors lp1.64M5.23%$23.06M
Versant venture management1.53M4.87%$21.44M

Top Institutional Shareholders by % of Total Assets

HolderShares% AssetsValue
Versant venture management1.53M15.16%$21.44M
Avidity partners management lp1.40M7.73%$34.18M
Fairmount funds management4.55M4.62%$63.98M
Acorn capital advisors786.76K3.14%$11.05M
Great point partners964.46K3.11%$13.55M
Vr adviser3.22M1.69%$45.25M
Samsara biocapital968.80K1.32%$13.61M
Bellevue group3.50M1.17%$49.20M
Foresite capital management vi320.00K0.98%$4.50M
Opaleye management427.61K0.79%$6.01M

Top Buyers

HolderShares% AssetsChange
Janus henderson group3.11M0.02%3.11M
Acorn capital advisors786.76K3.14%786.76K
Balyasny asset management402.49K0.01%402.49K
Vanguard group2.10M0.00%369.02K
Foresite capital management vi320.00K0.98%320.00K

Top Sellers

HolderShares% AssetsChange
Deep track capital, lp---2.28M
Frazier life sciences management---1.41M
Rtw investments, lp573.21K0.08%-876.07K
Blackrock funding, inc. /de2.31M0.00%-556.36K
Orbimed advisors185.01K0.05%-346.15K

New Positions

HolderShares% AssetsChangeValue
Janus henderson group3.11M0.02%3.11M$43.56M
Acorn capital advisors786.76K3.14%786.76K$11.05M
Balyasny asset management402.49K0.01%402.49K$5.65M
Foresite capital management vi320.00K0.98%320.00K$4.50M
Vanguard fiduciary trust219.50K0.00%219.50K$3.08M

Sold Out

HolderChange
Principal securities-5.00
Glenmede investment management, lp-53.00
Aster capital management (difc)-95.00
Strs ohio-900.00
Amalgamated bank-1.45K

Institutional Ownership Trends


DateHoldingsChange %SharesChange %OwnershipChange %Increased PositionChange %Decreased PositionChange %
Dec 31, 202575-1.32%20,804,363-34.20%520.82%5577.42%10-54.55%
Sep 30, 202529-59.15%6,448,004-79.55%220.18%9-87.14%14-
Jun 30, 202532-6,707,208-134,144-32---

Recent Insider Transactions


DateNameRoleActivityValue
May 16, 2025Frohlich Tom Chief Executive OfficerBuy$44.40K

Insider Transactions Trends


DateBuySell
2026 Q1--
2025 Q4--
2025 Q3--
2025 Q21-

JBIO Ownership FAQ


Who Owns Jade Biosciences?

Jade Biosciences shareholders are primarily institutional investors at 52.56%, followed by 0.04% insiders and 47.40% retail investors. The average institutional ownership in Jade Biosciences's industry, Biotech Stocks , is 379.48%, which Jade Biosciences falls below.

Who owns the most shares of Jade Biosciences?

Jade Biosciences’s largest shareholders are Fmr (7.09M shares, 22.59%), Fairmount funds management (4.55M shares, 14.52%), and Ra capital management (3.67M shares, 11.71%). Together, they hold 48.82% of Jade Biosciences’s total shares outstanding.

Does Blackrock own Jade Biosciences?

BlackRock is not among the top 10 institutional shareholders of Jade Biosciences.

Who is Jade Biosciences’s biggest shareholder by percentage of total assets invested?

Versant venture management is Jade Biosciences’s biggest shareholder by percentage of total assets invested, with 15.16% of its assets in 1.53M Jade Biosciences shares, valued at 21.44M$.

Try Tickergate Pro Free

Customize Everything. 100% Flexibility. Fast and Easy to Use (No code or Excel Needed)

  • Customize your own personal stocks lists, views and charts

  • Choose from hundreds of fields, up to 15 years of history

  • Conduct deep comparison analysis

  • Discover trending investment themes

  • Find your next best investment

  • Research stocks using tools